Literature DB >> 7681351

Interactions between excitatory amino acids and tachykinins in the rat spinal dorsal horn.

K I Rusin1, M C Jiang, R Cerne, M Randic.   

Abstract

Whole-cell patch-clamp technique of freshly isolated rat spinal dorsal horn (DH) neurons, intracellular recording from DH neurons in a slice preparation, and high performance liquid chromatography with fluorimetric detection of release of endogenous glutamate and aspartate from spinal cord slice following activation of primary afferent fibers were employed to investigate interactions between excitatory amino acids (EAA) and tachykinins [substance P (SP) and neurokinin A (NKA)]. Potentiation of N-methyl-D-aspartate (NMDA)-, quisqualate (QA)- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-, but not kainate-induced currents by SP and NKA was found. Spantide II, a claimed novel nonselective tachykinin antagonist, effectively blocked the SP (2 nM)-induced potentiation of the responses of DH neurons to NMDA. In the presence of glycine (0.1 microM), the SP-evoked increase of the NMDA-induced current was prevented. However, 7-chlorokynurenic acid (2 microM), a competitive antagonist at the glycine allosteric site of the NMDA receptor, led to the reestablishment of the SP effect. Brief high frequency electrical stimulation of primary afferent fibers produced a long-lasting potentiation of presumed monosynaptic and polysynaptic excitatory postsynaptic potentials and sustained enhanced release of endogenous glutamate (218.3 +/- 66.1%) and aspartate (286.3 +/- 58.0%). Possible functional implications of the observed phenomena are discussed in relation to transmission and integration of sensory information, including pain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681351     DOI: 10.1016/0361-9230(93)90261-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

2.  Substance P enhances excitatory synaptic transmission on spinally projecting neurons in the rostral ventromedial medulla after inflammatory injury.

Authors:  Liang Zhang; Donna L Hammond
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

3.  Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins.

Authors:  S Phenna; E Carpenter; C Peers; S Maudsley; J P Gent
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Modulation of hypoglossal motoneuron excitability by NK1 receptor activation in neonatal mice in vitro.

Authors:  K Yasuda; D M Robinson; S R Selvaratnam; C W Walsh; A J McMorland; G D Funk
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

5.  Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors.

Authors:  J C Marvizón; V Martínez; E F Grady; N W Bunnett; E A Mayer
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

6.  Sleep-inducing effect of substance P-cholera toxin A subunit in mice.

Authors:  Mark R Zielinski; Dmitry Gerashchenko
Journal:  Neurosci Lett       Date:  2017-09-01       Impact factor: 3.046

Review 7.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18

8.  Increased substance P and synaptic remodeling occur in the trigeminal sensory system with sustained osteoarthritic temporomandibular joint sensitivity.

Authors:  Megan M Sperry; Eric J Granquist; Beth A Winkelstein
Journal:  Pain Rep       Date:  2021-04-01

9.  Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-rat.

Authors:  Antje Brand; Ewan St J Smith; Gary R Lewin; Thomas J Park
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.